🔗 Share this article

A shadow economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Followers are encouraged to contact these accounts directly for source information, while also receiving promotional offers.

Active Trade on Social Networks

Additionally, a flourishing market exists on Telegram, where groups with numerous of participants share “before and after” images, injection guides and claims of next-day British shipping. Sellers promote the drug there before directing customers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, doctors and pharmacists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could lead to individuals injecting products of uncertain source.

Some professionals said the popularity for the experimental drug could be linked to the rising cost of approved slimming treatments such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the British medical regulations.

Several influencers try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate medicines, advertising, and consumer laws, potentially leading to fines, prosecution or prison.

Platform Response and Material Removal

Based on the social media company, the platform has removed violative material and banned related keywords and query recommendations. The company stated it was committed to maintaining the platform secure and investing in enhancing enforcement strategies.

Digital Marketplace Operations

Research also found groups with up to nine thousand members marketing the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays channels with numerous of members, populated with images of slimming results, glowing reviews and detailed instructions for mixing or administering at home.

After minutes of entering one group, a seller shared contact information, where the majority of purchases occur. The vendor sent an guidebook and promised delivery within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about weight, medical conditions or previous experience.

Item Details and Costs

Inside these communities, messages show black plastic parcels with postal service stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with purified liquid, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When asked how long a injector should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for Telegram stated it regularly moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering materials they cannot confirm. Even if the research behind retatrutide is valid, these digital products may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in demand to current price rises for approved slimming drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her staff has previously encountered patients injured by personal administration from unverified sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”

Producer Position

A representative from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company experimental product not yet authorized … may subject patients to possibly serious health risks”.